At the conclusion of this activity, learners should be able to:

• Recognize the uses of liver POCUS in clinical practice
• Understand the necessary steps to Liver POCUS training, billing and documentation

The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association for the Study of Liver Diseases designates this other <live and enduring> activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is planned in accordance with the AASLD Financial Disclosure Policy and the ACCME Standards for Integrity and Independence for Accredited Continuing Education by members of the CME Committee, the AASLD Maintenance of Certification (MOC) Committee, and the AASLD Governing Board. As an accredited provider, the AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare services used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardles of the amount in ineligible companies and their view of the relevance to the relationship to the education.

The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to ensure that content is objective, fair balanced, independent and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the prescribing information for each product for discussion of approved indications, contra-indications and warnings.

Jose Debes:
Nothing to Disclose

Amir Hossein Gougol:
Nothing to Disclose

Yuko Kono: 
Research Grants: Bracco Diagnostics, Canon Medical Systems Corporation